
Composition: Pantoprazole 40 mg (Gastro-Resistant) + Domperidone 30 mg (Prolonged Release)
GASTRIMOR contains Pantoprazole 40 mg and Domperidone 30 mg in a gastro-resistant and prolonged-release capsule formulation.
GASTRIMOR is indicated for the treatment of gastroesophageal reflux disease (GERD) and associated symptoms such as heartburn and acid regurgitation, where treatment with both acid suppression and prokinetic therapy is appropriate.